Sign Up to like & get recommendations! 0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-15302-3
Abstract: Candidozyma auris (formerly Candida auris) has emerged as a significant multidrug-resistant pathogen. Among 140 antifungal-resistant Candida spp. isolates, 120 were identified as C. auris using chromogenic agar, VITEK 2, and MALDI-TOF. Most cases (60%) were… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Mycoses"
DOI: 10.1111/myc.70085
Abstract: Candida (Candidozyma) auris has distinct genetic clades. Clade distinction is relevant for infection control and epidemiological purposes. State‐of‐the‐art typing methodologies for clade distinction are based on genomic approaches, such as short tandem repeat (STR) analysis… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00601-25
Abstract: ABSTRACT First identified in 2009, Candidozyma auris (formerly Candida auris) is an emerging multidrug-resistant fungus that can cause invasive infections with a crude mortality rate ranging from 30 to 60%. Currently, 30–50% of C. auris… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s528127
Abstract: Introduction Candidozyma auris (formerly known as Candida auris (C. auris)) can cause invasive infections with high mortality rates and the ability to colonize the skin, persist in healthcare environments, and cause healthcare-associated outbreaks. Certain patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Eurosurveillance"
DOI: 10.2807/1560-7917.es.2025.30.45.2500285
Abstract: BACKGROUND Candidozyma auris has emerged globally as a major threat to public health due to its outbreak causing capacity and antifungal resistance. Outbreaks have proven difficult to control despite enhanced infection prevention measures. Thus, national… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2025.1689176
Abstract: Purpose Candidozyma auris (C. auris) is an emerging fungal pathogen that is resistant to multiple drugs and poses a serious threat to global health. This study aimed to investigate the genetic diversity and antifungal resistance… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Antibiotics"
DOI: 10.3390/antibiotics14121206
Abstract: Background: Candidozyma auris has emerged globally as a multidrug-resistant pathogen with high rates of colonization and potential for invasive infection. Understanding the progression from colonization to infection and associated outcomes is limited. This study aimed… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Journal of Fungi"
DOI: 10.3390/jof10100698
Abstract: Limited antifungal treatment options and drug resistance require innovative approaches to effectively combat fungal infections. Combination therapy is a promising strategy that addresses these pressing issues by concurrently targeting multiple cellular sites. The drug targets… read more here.